BHIC · BioScience Health Innovations, Inc.
$4.08
+0.00 (+0.00%)
At close · Jul 20
Market Cap
$46.59M
Shares
11.42M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$5.69M
+208.3%
FY2025
Net Income
$642.09K
+638%
FY2025
Gross Margin
56.97%
-14pp
FY2025
Operating Margin
12.64%
+7.9pp
FY2025
Diluted EPS
$0.06
+500%
FY2025
Operating Cash Flow
$172.18K
+642.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $5.21M | $5.69M | $1.84M | $597.6K | $69.34K | $0 | $0 | |
| $2.38M | $2.45M | $536.08K | $113.19K | $9699 | — | — | |
| $2.83M | $3.24M | $1.31M | $484.41K | $59.64K | — | — | |
| — | 56.97% | 70.94% | 81.06% | 86.01% | — | — | |
| — | $37.54K | $25.91K | $0 | — | — | — | |
| — | — | — | — | — | — | $7682 | |
| $2.4M | $2.21M | $1.15M | $706.26K | $151.32K | $25.61K | — | |
| — | $0 | $0 | $0 | — | — | — | |
| $2.77M | $2.52M | $1.22M | $735.91K | $230.09K | $25.61K | — | |
| $62.35K | $719.05K | $87K | -$251.5K | -$170.45K | -$25.61K | -$7682 | |
| — | 12.64% | 4.72% | -42.09% | -245.81% | — | — | |
| — | — | — | — | $450 | $450 | — | |
| — | — | — | — | $8713 | — | — | |
| — | — | — | — | -$83.21K | — | — | |
| — | $76.96K | $0 | $0 | $0 | $0 | $0 | |
| -$14.62K | $642.09K | $87K | -$251.5K | -$170.45K | -$25.61K | -$7682 | |
| — | 11.29% | 4.72% | -42.09% | -245.81% | — | — | |
| USD/shares | — | $0.06 | $0.01 | -$0.04 | — | — | — |
| USD/shares | — | $0.06 | $0.01 | -$0.04 | — | — | — |
| shares | — | 10.98M | 10.48M | 8.44M | — | 1.37M | 948.42K |
| shares | — | 11.4M | 10.9M | 8.44M | — | 1.37M | 948.42K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
136.03×